MP Materials Corp.
MP Materials sells rare earth elements, including cerium, lanthanum, neodymium, praseodymium, and samarium, by mining and processing them at the Mountain Pass Rare Earth mine. MP Materials produces magnetic precursors and magnets through its Magnetics segment.
LOCKED
Market: NormalKey Catalysts & Risks
Completion of customer qualification and the start of commercial magnet shipments from Independence to General Motors, expected in the fourth quarter of 2026, is the nearest re-rating trigger, since on-time delivery would validate the shift from precursor seller to integrated magnet maker while a delay or yield problem would pressure a valuation that already assumes a successful ramp. Construction and commissioning of the 10X campus in Northlake, Texas, targeted for production near the end of 2028, is the largest value driver and the largest capital commitment, with government offtake and a minimum earnings guarantee offsetting demand risk but execution and heavy spending sitting over the next two years. Heavy rare earth commercialization is a second leg, with management targeting terbium and dysprosium output from the new separation circuit in the near term, samarium production around 2028, and a multi-year gadolinium oxide agreement that adds contracted revenue with locked-in economics. The Saudi refinery joint venture with Maaden and the Department of War, structured with government-funded non-recourse U.S. capital and a feasibility and definitive agreement process running toward a 2027 long-stop date, could extend refining capacity internationally with limited balance-sheet strain, though execution and partner pacing are largely outside MP's control. The renewal or expiry of China's export control regime, with an update expected around November 2026 on the current controls, is a two-sided policy catalyst because extended controls support ex-China heavy rare earth prices and customer urgency while easing would shrink scarcity premiums and could push NdPr pricing back toward the government floor.
MP's economics are now structurally tied to the U.S. government, which is set to become its largest shareholder, is the committed offtaker for all 10X output and provides the NdPr price floor, and the transaction also imposes governance consent rights that restrict board nominations of non-U.S. citizens and require government approval for major asset sales or fundamental transactions. Because the support depends on Congressional appropriations that future administrations can modify or challenge, revenue and policy risk are concentrated in a single counterparty and strategic flexibility is reduced, which matters for the 12-36 month case because a shift in appropriations, contract interpretation or political priorities would pressure both the earnings floor and the equity narrative. A second structural issue is execution and capital intensity, given that Independence and the much larger 10X campus are being built concurrently while magnet manufacturing know-how is concentrated in China, so delays, yield problems or cost overruns would absorb cash and push out the transition to sustained profitability. A further risk is that the pricing benchmark underpinning the government floor is still set in China and Chinese export controls create friction for equipment and reagent supply chains, with independent research arguing that concentrating federal support in one firm concentrates rather than resolves supply risk.
Research refreshed: 5th of October 2026
KPIs and Peer Benchmarks
| EV | P/E | Net Debt/EBIT | Revenue Growth | |
|---|---|---|---|---|
| NioCorp Dev… (NB) | 85.2M | N.M. | — | 0.0% |
| Energy Fuel… (UUUU) | 3.31B | N.M. | N.M. | -15.6% |
| MP Material… (MP) | 8.84B | N.M. | N.M. | 10.1% |
AI Opinion
Fundamentals
HOLD: The operational recovery is credible, but profitable commercialization remains unproven. Q2 NdPr sales volumes rose 127% and production rose 41%; government price protection and contracted offtake improve revenue resilience. However, Q3 sales are expected to remain roughly flat despite production exceeding 1,000 metric tons, and initial Q4 magnet shipments will be modest. Sustained magnet revenue, improved throughput and lower unit costs through 2027 are the decisive validation points; 10X production remains outside this outlook.
Peer Comparison
No Data
Macro Environment
The most direct external drivers are Chinese export controls, NdPr benchmark prices and durability of U.S. government support. The expected November 2026 export-control update could strengthen non-Chinese supply premiums or reverse scarcity sentiment; the price floor cushions Materials economics but does not eliminate policy or execution risk. The call's high-$90s/kg realized-price outlook plus approximately $10/kg PPA support illustrates that protection. A 5.28% Treasury yield pressures long-duration valuation; weak Materials breadth is secondary context, not an issuer-specific demand forecast.
Key Metrics
Revenue growth of 26.1% contrasts with aggregate operating margin of -33.10%, ROIC of -1.90%, asset turnover of 0.08x and FCF margin of -165.23%; Q2 gross-margin recovery shows these aggregate metrics do not fully capture recent improvement. Current EV/sales of 25.715x nevertheless embeds substantial execution expectations. Historical median fair value of $32.32 has only 1/5 confidence because of a share-count discontinuity and should not anchor a target; no reliable peer valuation supports the premium.
Insider Activity
No trades in the latest 90 days: no actionable current signal. Earlier 12-month activity included approximately $146.81 million sold versus $1.51 million bought, providing slightly bearish historical context, discounted for small relative CEO reductions and flagged automatic sales.
Income Statement
Q2 revenue grew 89% and gross margin recovered to 33.4%, materially improving on the aggregate ratio snapshot. The earnings call reported $126.1 million of revenue plus PPA income and $28.5 million of adjusted EBITDA; these measures are not equivalent to reported revenue or unadjusted EBITDA. Q2 operating loss remained $32.0 million and TTM operating loss $126.9 million. Precursor EBITDA margins above 40% are encouraging, but declining prepaid precursor revenue and magnet start-up costs could interrupt earnings progress.
Cash Flow
TTM operating cash flow was negative $84.0 million and FCF negative $504.6 million, driven by $420.6 million of PP&E spending and $130.2 million of working-capital absorption. FY2026 CapEx guidance of $500 million-$600 million keeps cash generation under pressure; Q2 spending included an approximately $80 million site purchase. The latest $6.8 million quarterly operating inflow is insufficient normalization evidence. Confirm the recovery through consecutive positive operating-cash-flow quarters, reduced inventory absorption and incremental commercial magnet sales through 2027.
Balance Sheet
June 30 cash and short-term investments of $1.45 billion compare with $934.6 million of debt and $1.96 billion of equity, providing substantial reported investment capacity. Cash-flow ending cash of $429.6 million may exclude investments rather than contradict liquidity, but the definitions require reconciliation. TTM financing inflows of $1.17 billion and substantial equity issuance show that funding and dilution remain material to per-share returns; debt maturities are unavailable.